Tag: Novamind - Psychedelic Alpha

Our 2022 Year in Review is now live.

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Post published:April 12, 2022
Post category:Press Release

Read more about the article Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

Post published:March 18, 2021
Post category:Press Release

Read more about the article Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Post published:March 1, 2021
Post category:Press Release

Read more about the article Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

Post published:February 22, 2021
Post category:Press Release

Read more about the article Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

Post published:January 26, 2021
Post category:Press Release

Read more about the article Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

Post published:January 13, 2021
Post category:Press Release

Read more about the article Novamind Completes Reverse Takeover Transaction

Novamind Completes Reverse Takeover Transaction

Post published:December 24, 2020
Post category:Press Release

Read more about the article Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Post published:December 22, 2020
Post category:Press Release

Read more about the article Novamind Closes Oversubscribed CAD$10 Million Private Placement

Novamind Closes Oversubscribed CAD$10 Million Private Placement

Post published:November 23, 2020
Post category:Press Release

Read more about the article Novamind and Hinterland Metals Enter into Amalgamation Agreement

Novamind and Hinterland Metals Enter into Amalgamation Agreement

Post published:November 17, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.